--- title: "Penumbra (PEN) stock listing, news and investor profile" url: "https://aibio.space/companies/penumbra/" publisher: "aibio.space (Biotech Investor Relations News)" summary: "Penumbra Inc (NYSE: PEN), United States. Listing facts, related biotech companies and news on aibio.space." --- PEN Penumbra Inc NYSE · United States # Penumbra (PEN) news Penumbra Inc is a public biotech or pharmaceutical company listed on NYSE under the ticker PEN, recorded under United States. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them. ## Latest Penumbra news We have not published a story on Penumbra yet. When there is news, it will appear here. ## Penumbra at a glance - **Ticker**: PEN - **Listing**: NYSE - **Country**: United States - **Cash, Sep 30, 2026**: $673.6 million ### Related companies - [MYOMO, INC.](https://aibio.space/companies/myomo/) NYSE: MYO - [GLAUKOS](https://aibio.space/companies/glaukos/) NYSE: GKOS - [Inspire Medical Systems](https://aibio.space/companies/inspire-medical-systems/) NYSE: INSP - [AURORA CANNABIS INC](https://aibio.space/companies/aurora-cannabis/) NASDAQ: ACB - [NovoCure](https://aibio.space/companies/novocure/) NASDAQ: NVCR - [Elanco Animal Health](https://aibio.space/companies/elanco-animal-health/) NYSE: ELAN - [Prenetics Global](https://aibio.space/companies/prenetics-global/) NASDAQ: PRE - [Co-Diagnostics](https://aibio.space/companies/diagnostics/) NASDAQ: CODX ### Also on NYSE - [Merck & Company](https://aibio.space/companies/merck-mrk-nyse/) MRK - [ARTIVION, INC.](https://aibio.space/companies/artivion/) AORT - [Xtant Medical Holdings](https://aibio.space/companies/xtant-medical/) XTNT - [Evommune](https://aibio.space/companies/evommune/) EVMN - [Johnson & Johnson](https://aibio.space/companies/johnson-johnson/) JNJ - [BECTON DICKINSON & CO](https://aibio.space/companies/becton-dickinson/) BDX ## Penumbra annual financials | Line | FY2025 | FY2024 | |---|---|---| | Revenue | [$1.40 billion](https://www.sec.gov/Archives/edgar/data/1321732/000132173226000007/) | [$1.19 billion](https://www.sec.gov/Archives/edgar/data/1321732/000132173226000007/) | | Net income (loss) | [$177.7 million](https://www.sec.gov/Archives/edgar/data/1321732/000132173226000007/) | [$14.0 million](https://www.sec.gov/Archives/edgar/data/1321732/000132173226000007/) | | Cash from operations | [$238.7 million](https://www.sec.gov/Archives/edgar/data/1321732/000132173226000007/) | [$168.5 million](https://www.sec.gov/Archives/edgar/data/1321732/000132173226000007/) | | Cash and equivalents | [$186.9 million](https://www.sec.gov/Archives/edgar/data/1321732/000132173226000043/) | [$324.4 million](https://www.sec.gov/Archives/edgar/data/1321732/000132173226000007/) | | Short-term investments | [$357.9 million](https://www.sec.gov/Archives/edgar/data/1321732/000132173226000043/) | [$15.7 million](https://www.sec.gov/Archives/edgar/data/1321732/000132173226000007/) | Latest balance sheet, Sep 30, 2026 (10-Q): cash and equivalents $254.3 million, plus short-term investments of $419.3 million, $673.6 million in all. Figures as reported to the SEC in XBRL; each one links to its filing. Not adjusted, not investment advice. ## Questions about Penumbra What is the ticker symbol of Penumbra? Penumbra Inc trades under the ticker PEN on NYSE. Where is Penumbra listed? Penumbra Inc is listed on NYSE. Which country or territory is Penumbra listed under? Our directory records Penumbra Inc under United States. Does aibio.space cover Penumbra? aibio.space lists Penumbra Inc among 2,820 public biotech companies and publishes its news here as stories appear. What was Penumbra's revenue last year? $1.40 billion for the fiscal year ended Dec 31, 2025, as reported to the SEC. Is Penumbra profitable? Penumbra Inc reported net income of $177.7 million for the fiscal year ended Dec 31, 2025, and generated $238.7 million of cash from operations, per its annual report to the SEC. How much cash does Penumbra have? $673.6 million in cash and short-term investments at Sep 30, 2026, per its 10-Q. ## Investor discussion: Penumbra Members talk about Penumbra (PEN). Reader posts, not aibio.space reporting, and not investment advice. Rules 1. **Securities violations are strictly forbidden.** No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information. 2. **Say whether you hold the stock.** Every post states long, short or no position. 3. **No paid or sponsored posts.** Do not post for anyone who pays or rewards you. 4. **No buy or sell calls and no price targets.** 5. **No accusations of crime or fraud against named people** unless you link a court filing or a regulator's release that makes them. 6. **No personal details and no spam.** No links at all for your first 7 days as a member. Posts that break the rules may be deleted without notice, and the account restricted or closed. See the [terms](https://aibio.space/terms/#discussion) and the [privacy policy](https://aibio.space/privacy/#discussion). ## Capital-markets timeline Financings, listing notices, splits, legal actions and other investor events at Penumbra, newest first. Each line links the filing it comes from. 1. 2026-05-07 Mergers Filed documents for a merger or acquisition. SEC Form 425. [Source](https://www.sec.gov/Archives/edgar/data/1321732/000132173226000025/pen-xspecialmeetingvoteres.htm) ## Stock chart Price chart and quote supplied by TradingView, delayed as the exchange requires. It loads only if you choose to show it. Information only, not investment advice. [Open NYSE:PEN on TradingView](https://www.tradingview.com/symbols/NYSE-PEN/). ## Listing details Penumbra Inc is a public biotech or pharmaceutical company listed on NYSE under the ticker PEN, recorded under United States. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them. - **Company**: Penumbra Inc - **Ticker**: PEN - **Listing**: NYSE - **Country or territory**: United States Listing facts come from our company directory, researched on October 22, 2026. A listing record does not certify that a security currently trades. [Tell us about a change](https://aibio.space/reputation/#update). Work at this company? [Claim this page](https://aibio.space/claim/). Published and maintained by aibio.space. Not investment advice. [How we work](https://aibio.space/disclosures/). Who manages this page **This page is managed by aibio.space.** The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. [How we work](https://aibio.space/disclosures/#paid) · [Terms](https://aibio.space/terms/#news) · [Request a correction](https://aibio.space/reputation/#update) --- Source page: https://aibio.space/companies/penumbra/. Facts in aibio.space stories are checked against company filings and releases; opinion is labelled. Cite as: aibio.space, "Penumbra (PEN) stock listing, news and investor profile", 2026-10-31, https://aibio.space/companies/penumbra/